Evaluation of stepwise insulin treatment as an add-on to current oral antidiabetic drugs therapy in Japanese patients with type 2 diabetes: STEADY study

Albiglutide, a weekly GLP-1 receptor agonist, improves glycemic parameters in Japanese patients with type 2 diabetes over 1 year when added to single oral antidiabetic drugs

Current Medical Research and Opinion ◽

10.1080/03007995.2016.1261817 ◽

2016 ◽

Vol 33 (3) ◽

pp. 431-438 ◽

Cited By ~ 3

Author(s):

Inaha Okuda ◽

Timothy H. Wilson ◽

Lin Yue ◽

Hiromu Nakajima ◽

Molly C. Carr ◽

...

Keyword(s):

Type 2 Diabetes ◽

Receptor Agonist ◽

Japanese Patients ◽

Antidiabetic Drugs ◽

Oral Antidiabetic Drugs ◽

Incidence and predictors of hypoglycemia in Japanese patients with type 2 diabetes treated by insulin glargine and oral antidiabetic drugs in real-life: ALOHA post-marketing surveillance study sub-analysis

Diabetology & Metabolic Syndrome ◽

10.1186/1758-5996-6-20 ◽

2014 ◽

Vol 6 (1) ◽

Cited By ~ 10

Author(s):

Masato Odawara ◽

Takashi Kadowaki ◽

Yusuke Naito

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Real Life ◽

Japanese Patients ◽

Antidiabetic Drugs ◽

Oral Antidiabetic Drugs ◽

Oral Antidiabetic ◽

Post Marketing Surveillance ◽

Post Marketing

Cross sectional study on proportion of sulfonylureas among various oral antidiabetic drugs using for Japanese patients with type 2 diabetes, analyzed from NSAID Study-2

Diabetology International ◽

10.1007/s13340-021-00520-7 ◽

2021 ◽

Author(s):

Keiko Arai ◽

Tetsuo Nishikawa ◽

Shin-ichiro Shirabe ◽

Yoko Matsuzawa ◽

Shigeyuki Ohtsu ◽

...

Keyword(s):

Type 2 Diabetes ◽

Japanese Patients ◽

Cross Sectional Study ◽

Antidiabetic Drugs ◽

Sectional Study ◽

Oral Antidiabetic Drugs ◽

Cross Sectional ◽

Efficacy and safety of luseogliflozin added to various oral antidiabetic drugs in Japanese patients with type 2 diabetes mellitus

Journal of Diabetes Investigation ◽

10.1111/jdi.12316 ◽

2015 ◽

Vol 6 (4) ◽

pp. 443-453 ◽

Cited By ~ 33

Author(s):

Yutaka Seino ◽

Nobuya Inagaki ◽

Masakazu Haneda ◽

Kohei Kaku ◽

Takashi Sasaki ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Japanese Patients ◽

Antidiabetic Drugs ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Remission of hyperglycemia after withdrawal of oral antidiabetic drugs in Japanese patients with early-stage type 2 diabetes

Journal of Diabetes Investigation ◽

10.1111/jdi.12813 ◽

2018 ◽

Vol 9 (5) ◽

pp. 1119-1127 ◽

Cited By ~ 1

Author(s):

Hidenori Hirukawa ◽

Mitsuru Hashiramoto ◽

Yukio Tanizawa ◽

Kohei Kaku ◽

Keyword(s):

Type 2 Diabetes ◽

Early Stage ◽

Japanese Patients ◽

Antidiabetic Drugs ◽

Oral Antidiabetic Drugs ◽

Abstract #292 Efficacy of Hydroxychloroquine when added in Subjects with Inadequately Controlled Type 2 Diabetes Mellitus Treated with Basal Insulin and Two Other Oral Antidiabetic Drugs

Endocrine Practice ◽

10.1016/s1530-891x(20)46636-4 ◽

2019 ◽

Vol 25 ◽

pp. 119-120

Author(s):

Arjun Baidya ◽

Ajay Chhabra

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Basal Insulin ◽

Antidiabetic Drugs ◽

Oral Antidiabetic Drugs ◽

2224-PUB: Comparative Effectiveness of Second-Line Initiation of Basal Insulin Therapy vs. Oral Antidiabetic Drugs Added to Metformin among Patients with Type 2 Diabetes in Taiwan

Diabetes ◽

10.2337/db19-2224-pub ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 2224-PUB

Author(s):

PIN-HAO CHEN ◽

SHIHCHEN KUO ◽

HUANG-TZ OU

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Comparative Effectiveness ◽

Basal Insulin ◽

Antidiabetic Drugs ◽

Second Line ◽

Oral Antidiabetic Drugs ◽

Efficacy and safety of insulin glargine/lixisenatide fixed‐ratio combination (iGlarLixi) in Japanese patients with type 2 diabetes mellitus inadequately controlled on basal insulin and oral antidiabetic drugs: The LixiLan JP‐L randomized clinical trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.14005 ◽

2020 ◽

Vol 22 (S4) ◽

pp. 3-13 ◽

Cited By ~ 3

Author(s):

Hideaki Kaneto ◽

Akane Takami ◽

Robert Spranger ◽

Atsushi Amano ◽

Daisuke Watanabe ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Clinical Trial ◽

Fixed Ratio ◽

Japanese Patients ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10)

Diabetes & Metabolism ◽

10.1016/j.diabet.2019.101117 ◽

2020 ◽

Vol 46 (2) ◽

pp. 100-109 ◽

Cited By ~ 26

Author(s):

M.S. Capehorn ◽

A.-M. Catarig ◽

J.K. Furberg ◽

A. Janez ◽

H.C. Price ◽

...

Keyword(s):

Type 2 Diabetes ◽

Antidiabetic Drugs ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Once Daily ◽

Insulin glargine in combination with oral antidiabetic drugs as a cost-equivalent alternative to conventional insulin therapy in type 2 diabetes mellitus

Wiener klinische Wochenschrift ◽

10.1007/s00508-005-0429-5 ◽

2005 ◽

Vol 117 (17) ◽

pp. 593-598 ◽

Cited By ~ 7

Author(s):

Monika Lechleitner ◽

Michael Roden ◽

Eva Haehling ◽

Markus Mueller

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Insulin Glargine ◽

Insulin Therapy ◽

Antidiabetic Drugs ◽

Oral Antidiabetic Drugs ◽

Conventional Insulin Therapy ◽